NDRI
We provide human biospecimens worldwide to advance biomedical/bioscience research & development.

Services & Capabilities
NDRI distributes biospecimen to hundreds of investigators around the world who are working to advance many areas of science and healthcare.

Strategic Initiatives
We partner directly with academic researchers and corporate investigators to provide them with high-quality human tissues that meet the needs of demanding research projects.

Tissue Recovery Partners
Our partnerships with nationwide organ and tissue donation programs enable NDRI to obtain human biospecimens for scientific research from a diverse pool of normal and diseased donors.

Become A Donor
NDRI’s private donor program gives individuals and their families an opportunity to leave a meaningful legacy and ensure that investigators have access to the human tissues and organs that are so critical to their research.
The National Disease Research Interchange (NDRI) is a not-for-profit organization with over 40 years of experience in providing human organs and tissue from a diverse pool of normal and diseased donors to support the advancement of biomedical research.
Our partnerships with nationwide organ and tissue donation programs enable NDRI to obtain biospecimens from all body systems. NDRI utilizes a prospective procurement model and project-specific collection protocols to provide biospecimens that meet the experimental needs of each project.
See how NDRI empowers research
- Biospecimen acquisition and processing tailored to specific protocol requirements
- Responsive 24/7/365 call center for requests and biospecimen distribution
- 40 years of experience distributing nearly every human tissue and organ
- Informed consent and regulation compliant material handling
Large Scale NIH-funded Programs
NDRI receives funding from the NIH to support the recovery and distribution of donated human organs and tissues for use in research programs across multiple disciplines. NDRI has the ability to source organs and tissues at the volumes needed for large-scale research programs.
The Human Tissue and Organs for Research Resource (HTORR) Program is an NIH-funded initiative that provides academic biomedical investigators with donated normal and diseased human tissues and organs recovered from a diverse donor pool.
Somatic Mosaicism Across Human Tissues (SMaHT) Network is an NIH Common Fund program that aims to transform our knowledge of how much genetic variation there is in the cells and tissues throughout our bodies.
The Developmental Genotype-Tissue Expression (dGTEx) project is a new, NIH-supported initiative to establish a scientific research resource of gene expression patterns in multiple healthy reference neonatal, pediatric, and adolescent tissues.
Latest NDRI News
NDRI Recognized for Workplace Culture with 2026 Quantum Certified Workplace™ Designation
Designation acknowledges NDRI’s sustained commitment to building thriving teams and a strong workplace culture National Disease Research Interchange (NDRI) has been...
dGTEx Project Releases First Data on Pediatric Genetic Development
This initiative aims to help researchers develop more successful treatments for childhood diseases The National Disease Research Interchange (NDRI) is proud to...
NDRI Announces Fall 2025 Pilot Award Program Honorees
Winners will receive human biospecimens and support for pilot studies in Crohn’s Disease, diabetes, and pulmonary diseases The National Disease Research Interchange...
NDRI Board Member Honored with Award from Research!America
The National Disease Research Interchange (NDRI) is proud to congratulate Board Member Arthur Rubenstein, MBBCh, on receiving Research!America’s Herbert Pardes Family...
Research Spotlight: Early Gene Therapy Study Offers New Hope for Patients with Heart Failure
First-in-human trial demonstrates the safety and feasibility of a heart-targeted AAV gene therapy, with key molecular validation supported by NDRI-sourced human tissue....
Research Spotlight: New Research Shows Promise in Protecting the Eye from Diabetic Damage
Study supported by NDRI-sourced, generously donated, human tissue, identifies a potential treatment that preserves vision in Diabetic Retinal Disease Scavenging...



